CEBRX | MEDBX | CEBRX / MEDBX | |
Total Expense Ratio | 0.75 | 1.81 | 41% |
Annual Report Gross Expense Ratio | 0.75 | 1.82 | 41% |
Fund Existence | 13 years | 23 years | - |
Gain YTD | 8.069 | 6.272 | 129% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 330M | 7.47B | 4% |
Annual Yield % from dividends | 5.37 | 4.32 | 124% |
Returns for 1 year | 7.96 | 6.46 | 123% |
Returns for 3 years | 28.30 | 25.54 | 111% |
Returns for 5 years | 10.58 | 5.47 | 193% |
Returns for 10 years | 48.81 | 33.02 | 148% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
PCBIX | 47.91 | -0.01 | -0.02% |
Principal MidCap Institutional | |||
RTSGX | 6.15 | -0.01 | -0.16% |
Transamerica Small Cap Growth R6 | |||
PEPSX | 31.82 | -0.07 | -0.22% |
Principal Glb Emerging Markets R5 | |||
PIEQX | 19.29 | -0.15 | -0.77% |
T. Rowe Price International Eq Index | |||
VDSRX | 24.80 | -0.22 | -0.88% |
Victory Diversified Stock R6 |